Experts are questioning aspects of some of the Ebola guidelines that go beyond current Centers for Disease Control and Prevention (CDC) recommendations, especially those that call for suspending certain routine lab tests, according to an article on Infection Control Today.
A commentary in the journal Transfusion suggests that most individuals with suspected Ebola will have a fever due to another cause, and forgoing such testing may compromise patients' health more than any reduction in the risks to laboratory personnel.
The article says that all laboratory directors must work with infection control and safety experts to evaluate their hospital policies on potentially infectious patients to provide a safe environment.
Disinfectant Dispensers in Healthcare Facilities Often Fail to Deliver Safe Concentrations: Study
Duke University Health System Receives $50 Million for Proton Beam Therapy Center
UT Southwestern Experiences Data Breach Through Calendar Tool
Protecting Patient Data: Strategies and Tactics
Duke Health to Acquire Lake Norman Regional Medical Center